A special issue on cancer immunotherapy.
作者信息
Wang Rong-Fu
机构信息
Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, TX 77030, USA.
Department of Microbiology and Immunology, Weill Cornell Medical College, Cornell University, New York, NY 10065, USA.
出版信息
Cell Res. 2017 Jan;27(1):1-2. doi: 10.1038/cr.2017.1.
Abstract
摘要
相似文献
1
A special issue on cancer immunotherapy.一期关于癌症免疫疗法的特刊。
Cell Res. 2017 Jan;27(1):1-2. doi: 10.1038/cr.2017.1.
2
Regulatory T cells: a new frontier in cancer immunotherapy.调节性T细胞：癌症免疫疗法的新前沿。
Adv Exp Med Biol. 2008;622:255-60. doi: 10.1007/978-0-387-68969-2_20.
3
T-regulatory cell modulation: the future of cancer immunotherapy?调节性T细胞调节：癌症免疫疗法的未来？
Br J Cancer. 2009 Jun 2;100(11):1697-703. doi: 10.1038/sj.bjc.6605040. Epub 2009 Apr 21.
4
Regulatory T cells, as a target in anticancer immunotherapy.调节性T细胞作为抗癌免疫疗法的一个靶点。
Immunotherapy. 2017 Jun;9(8):623-627. doi: 10.2217/imt-2017-0057.
5
Regulatory T cells, tumour immunity and immunotherapy.调节性T细胞、肿瘤免疫与免疫疗法。
Nat Rev Immunol. 2006 Apr;6(4):295-307. doi: 10.1038/nri1806.
6
The in vitro generation of effector lymphocytes and their employment in tumor immunotherapy.效应淋巴细胞的体外生成及其在肿瘤免疫治疗中的应用。
Adv Cancer Res. 1983;38:171-287. doi: 10.1016/s0065-230x(08)60190-6.
7
Cancer: Tumour-specific ablation of Treg cells induces anticancer response.癌症：肿瘤特异性清除调节性T细胞可诱导抗癌反应。
Nat Rev Drug Discov. 2016 Sep 29;15(10):676-7. doi: 10.1038/nrd.2016.198.
8
Immunology in tumor therapeutics: an overview.肿瘤治疗中的免疫学：概述
Del Med J. 1980 Apr;52(4):197-209.
9
[Suppression of tumor antigen-specific T cell immune responses by regulatory T cells].[调节性T细胞对肿瘤抗原特异性T细胞免疫反应的抑制作用]
Gan To Kagaku Ryoho. 2014 Sep;41(9):1057-61.
10
Immune monitoring in cancer immunotherapy.癌症免疫治疗中的免疫监测
Ernst Schering Res Found Workshop. 2000(30):75-97. doi: 10.1007/978-3-662-04183-3_5.
引用本文的文献
1
Pan-Cancer Analyses Confirmed the Ferroptosis-Related Gene as a Prognostic Biomarker for Cancer.泛癌分析证实铁死亡相关基因作为癌症的预后生物标志物。
Int J Gen Med. 2022 Mar 5;15:2501-2513. doi: 10.2147/IJGM.S341502. eCollection 2022.
2
Inhibition of MAN2A1 Enhances the Immune Response to Anti-PD-L1 in Human Tumors.抑制 MAN2A1 增强了抗 PD-L1 治疗人类肿瘤的免疫反应。
Clin Cancer Res. 2020 Nov 15;26(22):5990-6002. doi: 10.1158/1078-0432.CCR-20-0778. Epub 2020 Jul 28.
3
Cryo-thermal therapy induces macrophage polarization for durable anti-tumor immunity.冷冻-热疗诱导巨噬细胞极化以产生持久的抗肿瘤免疫。
Cell Death Dis. 2019 Mar 4;10(3):216. doi: 10.1038/s41419-019-1459-7.
本文引用的文献
1
Breakthrough of the year 2013. Cancer immunotherapy.2013年度重大突破。癌症免疫疗法。
Science. 2013 Dec 20;342(6165):1432-3. doi: 10.1126/science.342.6165.1432.
2
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias.自体 CD19 靶向 T 细胞过继转移治疗复发或化疗耐药 B 细胞白血病患者的安全性和持久性。
Blood. 2011 Nov 3;118(18):4817-28. doi: 10.1182/blood-2011-04-348540. Epub 2011 Aug 17.
3
Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia.嵌合抗原受体修饰的 T 细胞治疗慢性淋巴细胞白血病。
N Engl J Med. 2011 Aug 25;365(8):725-33. doi: 10.1056/NEJMoa1103849. Epub 2011 Aug 10.
4
Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1.采用针对 NY-ESO-1 的基因工程化淋巴细胞治疗转移性滑膜细胞肉瘤和黑色素瘤患者的肿瘤消退。
J Clin Oncol. 2011 Mar 1;29(7):917-24. doi: 10.1200/JCO.2010.32.2537. Epub 2011 Jan 31.
5
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma.经过基因工程改造以共表达肿瘤特异性受体的病毒特异性T细胞：在神经母细胞瘤患者中的持久性和抗肿瘤活性
Nat Med. 2008 Nov;14(11):1264-70. doi: 10.1038/nm.1882. Epub 2008 Nov 2.
6
B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion.B7-H1是B7家族的第三个成员，它共刺激T细胞增殖和白细胞介素-10的分泌。
Nat Med. 1999 Dec;5(12):1365-9. doi: 10.1038/70932.
7
Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen.克隆编码MHC II类限制性抗原的基因：突变的CDC27作为一种肿瘤抗原。
Science. 1999 May 21;284(5418):1351-4. doi: 10.1126/science.284.5418.1351.
8
A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening.一种通过自体抗体筛选在人类癌症中异常表达的睾丸抗原。
Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1914-8. doi: 10.1073/pnas.94.5.1914.
9
Enhancement of antitumor immunity by CTLA-4 blockade.通过阻断CTLA-4增强抗肿瘤免疫力。
Science. 1996 Mar 22;271(5256):1734-6. doi: 10.1126/science.271.5256.1734.
10
Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors.通过由抗体结合域以及免疫球蛋白和T细胞受体的γ或ζ亚基组成的嵌合单链对细胞毒性淋巴细胞进行特异性激活和靶向。
Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):720-4. doi: 10.1073/pnas.90.2.720.
Zotero 插件